$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The FRET-based GA biosensor nlsGPS1 provides a quantitative method to report and measure GA hormone gradients in multicellular plants. FRET-based biosensors can quantify dynamics with an improved spatiotemporal resolution over direct detection by mass spectrometry and indirect measurement by transcriptional reporters or signaling-protein-degradation-based methods12,13. High-resolution cellular imaging in diverse tissue-types can yield meaningful insights into GA biology and spark new hypotheses regarding the regulation and function of GA accumulations in a multicellular context. For example, monitoring changes in the nlsGPS1 biosensor in specific GA biosynthetic, catabolic, and transport mutants, as well as during spatiotemporally induced perturbations, could be very informative to test specifically how GA gradients are established in the root and address root cell responses to GA gradients. The sensor could be used in other model and crop species to test the conservation of the mechanisms that control the GA-mediated control of seed germination, cellular elongation, and flowering.
The critical steps in the FRET-based imaging of the nlsGPS1 biosensor are that, 1) the pixels should not be saturated during the quantitative FRET analysis, 2) imaging parameters such as "detector gain" should be kept constant for the donor emission (DxDm) and acceptor emission (DxAm) acquisitions, 3) control nlsGPS1-NR lines should be used to rule out artefacts, and 4) samples should be prepared to minimize drift and focal-change issues. Additionally, the environmental conditions in which samples are grown are important to control since GA levels are sensitive to environmental conditions such as light duration and light intensity14,15,16,17. A key limitation of this type of analysis is that a high signal-to-noise ratio is required for imaging due to the increase in noise inherent in ratiometric imaging. Thus, nlsGPS1 imaging will not be useful for tissues and organs that are not amenable to ratiometric fluorescence microscopy using cyan and yellow fluorescent proteins—for example, deeper tissues where fluorescent proteins are poorly detected. On the other hand, ratiometric readouts are often preferred over intensiometric readouts, because an internal control is helpful to rule out artefacts stemming from changes in biosensor expression, stability, brightness, or detectability in a given cell, tissue, or condition. For example, FRET biosensor imaging and image analyses have also been used to study a variety of ligands in a variety of tissues5,6,18,19,20,. The imaging experiments and image analyses reported here can be modified to suit new imaging methods, such as light sheet microscopy, that could yield novel insights in, for example, deeper root tissue-types.
The first-generation nlsGPS1 biosensor is a high-affinity sensor that provides a high-resolution map of GA gradients that can also report on intracellular increases in GA following exogenous GA treatments. One of the current limitations of nlsGPS1 is that the sensor is not rapidly reversible and, thus, reports not on steady-state GA levels but, likely, on the maximum recent GA concentration in the solution of interest. The precise turnover rate for the sensor is also not known and this, combined with low reversibility, precludes detection of endogenous GA depletions that might be happening within a minutes to few a hours in some tissue-types. It is also important to note that nlsGPS1 has a high affinity for GA4 (Kd = 24 nM) compared to other GA forms (GA3 Kd= 240 nM, GA1 Kd = 110 nM) when imaging other bioactive GAs7. Future generations of GA biosensors can be engineered to increase reversibility while maintaining high affinity or to exhibit different specificities for the various precursor, bioactive, or catabolite GAs.